Sonder Futures — 2023 Investments
3 investments dated 2023 · listed companies and verified rows first · show all
HealthtechAddison, US
Amir Abolfathi(Director)Lea Ellermeier(Executive Officer, Director)Karen Long(Director)
BoardKate Garrett(Director)inCindy Roark(Director)
Board seatFrederic Moll· per SEC Form D · $11M raise · filed Apr 2023
Co-investorsSonder Capital
HealthtechWoodside, US
Jay Watkins(Director)Francis P. Grillo(Director)Todd Alamin(Director)Don Johnson(Director)Richard Treadwell(Executive Officer, Director)
Board seatJay Watkins· per SEC Form D · $10.3M raise · filed Sep 2023
RefleXion Medical develops SCINTIX autonomous radiotherapy, an external beam theranostic oncology platform that uses biological signals from radiopharmaceutical-labeled cancer cells to deliver real-time, motion-managed radiation to lung and bone tumors from primary or metastatic disease.
BiotechHealthtechMedical DevicesHayward, US
Akshay Nanduri(Executive Officer, Director)Samuel Mazin(Executive Officer, Director)
Board seatJay Watkins· per SEC Form D · $201.4M raise · filed Nov 2023
Co-investorsAscension VenturesCatalio Capital Management, LPPfizer Venture InvestmentsSofinnova PartnersSonder CapitalVenrock
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.